Sunday, 1 September 2013

European Commission Approves Genzyme’s Once-Daily, Oral Multiple Sclerosis Treatment Aubagio® (teriflunomide) « New Drug Approvals

European Commission Approves Genzyme’s Once-Daily, Oral Multiple Sclerosis Treatment Aubagio® (teriflunomide) « New Drug Approvals

No comments:

Post a Comment